PINK:XSNX

Xsunx Stock Company Profile

Healthcare > Biotechnology

Buy XSNX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 02, 2026

Information

8834 Mayfield Road, Suite C

Chesterland OH 44026

440 644 1027

novaccessglobal.com

Industry: Biotechnology

Sector: Healthcare

Description

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by